Tamara Maes
Net worth: 18 M $ as of 31/05/2026
Net worth: 18 M $ as of 31/05/2026
Tamara Maes was the founder of Oryzon Genomics SA, holding the title of First Deputy Chairman from 2000 to 2025.
Current jobs include Director at Mendelion Lifesciences SL, Member at Alzheimers Drug Discovery Foundation since 2016, and Scientific Coordinator at Oncnosis Pharma AIE.
Education includes a doctorate from Ghent University.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ORYZON GENOMICS SA 6.24% | 26/06/2025 | 4,985,060 ( 6.24% ) | 18 M $ | 31/05/2026 |
| Companies | Position | Start |
|---|---|---|
Oncnosis Pharma AIE | Corporate Officer/Principal | - |
Mendelion Lifesciences SL
Mendelion Lifesciences SL Engineering & ConstructionIndustrial Services Constructs commercial buildings | Director/Board Member | - |
Alzheimers Drug Discovery Foundation
Alzheimers Drug Discovery Foundation BiotechnologyHealth Technology Operates as a research organisation | Corporate Officer/Principal | 01/01/2016 |
| Companies | Position | End |
|---|---|---|
| ORYZON GENOMICS S.A. | Founder | 28/02/2025 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
Oryzon Genomics SA
Oryzon Genomics SA BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops epigenetics-based therapeutics | Health Technology |
Ghent University
Ghent University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alzheimers Drug Discovery Foundation
Alzheimers Drug Discovery Foundation BiotechnologyHealth Technology Operates as a research organisation | Health Technology |
Oncnosis Pharma AIE | |
Mendelion Lifesciences SL
Mendelion Lifesciences SL Engineering & ConstructionIndustrial Services Constructs commercial buildings | Industrial Services |
Select your edition
All financial news and data tailored to specific country editions